Molecular Partners AG Files 6-K with June 1 Press Release
Ticker: MOLN · Form: 6-K · Filed: Jun 3, 2024 · CIK: 1745114
Sentiment: neutral
Topics: filing, press-release
TL;DR
Molecular Partners AG dropped a press release on June 1st, filed it with the SEC today.
AI Summary
Molecular Partners AG filed a Form 6-K on June 3, 2024, to report a press release issued on June 1, 2024. The filing incorporates this press release by reference, which is the primary disclosure for this period.
Why It Matters
This filing indicates that Molecular Partners AG has made a public announcement on June 1, 2024, which is now officially part of their SEC disclosures.
Risk Assessment
Risk Level: low — This is a routine filing of a press release, not indicating any immediate material changes or events.
Key Players & Entities
- Molecular Partners AG (company) — Registrant
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report a press release issued by Molecular Partners AG on June 1, 2024, and to incorporate it by reference.
When was the press release issued?
The press release was issued on June 1, 2024.
What is the filing date of this Form 6-K?
This Form 6-K was filed on June 3, 2024.
Does Molecular Partners AG file annual reports under Form 20-F?
Yes, Molecular Partners AG indicated with an 'X' that it files annual reports under cover of Form 20-F.
What is the principal executive office address of Molecular Partners AG?
The principal executive office address is Wagistrasse 14, 8952 Zurich-Schlieren, Switzerland.
Filing Stats: 170 words · 1 min read · ~1 pages · Grade level 11.6 · Accepted 2024-06-03 17:06:11
Filing Documents
- f6k_060324.htm (6-K) — 3KB
- exh_991.htm (EX-99.1) — 10KB
- 0001171843-24-003244.txt ( ) — 15KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Molecular Partners AG (Registrant) Date: June 1, 2024 /s/ PATRICK AMSTUTZ Patrick Amstutz Chief Executive Officer